» Articles » PMID: 20065971

Association Between Single-slice Measurements of Visceral and Abdominal Subcutaneous Adipose Tissue with Volumetric Measurements: the Framingham Heart Study

Overview
Specialty Endocrinology
Date 2010 Jan 13
PMID 20065971
Citations 93
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Volumetric visceral abdominal adipose tissue (VAT) and subcutaneous abdominal adipose tissue (SAT) as measured by computed tomography (CT) are associated with metabolic risk factors. We sought to identify the correlations of VAT and SAT between area-based measures at different anatomic locations with volumetric measurements to identify the optimal anatomic site, and to relate measurements at this site with metabolic risk factors.

Methods: We measured SAT and VAT volumes across the total imaging volume, whereas we measured SAT and VAT area at seven predefined anatomic landmarks in 200 participants from the Framingham Heart Study (mean age 54 years, 50% women) who underwent abdominal multi-detector CT. Correlation coefficients were used to assess the association between area measurements and volumes as well as metabolic risk factors stratified by gender.

Results: Area-based measurements of SAT and VAT obtained at all anatomic landmarks were strongly associated with SAT and VAT volumes (all r>0.93, P<0.0001 and r>0.87, P<0.0001, for women and men; respectively). Consistently, area-based measurements of SAT and VAT obtained at L(3/4) were most strongly associated with volumetric measured VAT and SAT independent of age (both r=0.99 in men, r=0.96 for SAT and r=0.99 for VAT in women, all P-value <0.0001) and were similarly correlated with risk factors compared with SAT and VAT volumes (all P<0.05 for fasting plasma glucose, triglycerides, high-density lipoprotein, systolic blood pressure).

Conclusion: Among area-based measurements of SAT and VAT, those obtained at the level of L(3/4) were strongly associated with SAT and VAT volumes and cardio-metabolic risk factors in both men and women.

Citing Articles

Deep learning-based body composition analysis from whole-body magnetic resonance imaging to predict all-cause mortality in a large western population.

Jung M, Raghu V, Reisert M, Rieder H, Rospleszcz S, Pischon T EBioMedicine. 2024; 110:105467.

PMID: 39622188 PMC: 11647620. DOI: 10.1016/j.ebiom.2024.105467.


Unhealthy visceral fat is associated with improved efficacy of immunotherapy in endometrial cancer.

Steinhauser M J Clin Invest. 2024; 134(17).

PMID: 39225094 PMC: 11364398. DOI: 10.1172/JCI183675.


Prediction of visceral adipose tissue magnitude using a new model based on simple clinical measurements.

Torun C, Ankarali H, Castur L, Uzunlulu M, Erbakan A, Akbas M Front Endocrinol (Lausanne). 2024; 15:1411678.

PMID: 39119005 PMC: 11307439. DOI: 10.3389/fendo.2024.1411678.


Body mass index and adiposity influence responses to immune checkpoint inhibition in endometrial cancer.

Gomez-Banoy N, Ortiz E, Jiang C, Dagher C, Sevilla C, Girshman J medRxiv. 2024; .

PMID: 38883775 PMC: 11178024. DOI: 10.1101/2024.06.07.24308618.


Establishment of a novel weight reduction model after laparoscopic sleeve gastrectomy based on abdominal fat area.

Feng T, Hu S, Song C, Zhong M Front Surg. 2024; 11:1390045.

PMID: 38826810 PMC: 11140024. DOI: 10.3389/fsurg.2024.1390045.


References
1.
Borkan G, Gerzof S, Robbins A, Hults D, Silbert C, Silbert J . Assessment of abdominal fat content by computed tomography. Am J Clin Nutr. 1982; 36(1):172-7. DOI: 10.1093/ajcn/36.1.172. View

2.
Yoshizumi M, Kashani A, Palmer J, Lee G, Mondino B . High dose intramuscular methylprednisolone in experimental Staphylococcus aureus endophthalmitis. J Ocul Pharmacol Ther. 1999; 15(1):91-6. DOI: 10.1089/jop.1999.15.91. View

3.
Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N . Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007; 117(4):e25-146. DOI: 10.1161/CIRCULATIONAHA.107.187998. View

4.
Kuk J, Church T, Blair S, Ross R . Does measurement site for visceral and abdominal subcutaneous adipose tissue alter associations with the metabolic syndrome?. Diabetes Care. 2006; 29(3):679-84. DOI: 10.2337/diacare.29.03.06.dc05-1500. View

5.
Demerath E, Reed D, Rogers N, Sun S, Lee M, Choh A . Visceral adiposity and its anatomical distribution as predictors of the metabolic syndrome and cardiometabolic risk factor levels. Am J Clin Nutr. 2008; 88(5):1263-71. PMC: 2801427. DOI: 10.3945/ajcn.2008.26546. View